- Home
- TOP vs RNXT Comparison
TOP vs RNXT Comparison
Compare TOP & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOP
- RNXT
- Stock Information
- Founded
- TOP 2015
- RNXT 2012
- Country
- TOP Singapore
- RNXT United States
- Employees
- TOP N/A
- RNXT N/A
- Industry
- TOP Investment Bankers/Brokers/Service
- RNXT Biotechnology: Pharmaceutical Preparations
- Sector
- TOP Finance
- RNXT Health Care
- Exchange
- TOP Nasdaq
- RNXT Nasdaq
- Market Cap
- TOP 43.0M
- RNXT 35.2M
- IPO Year
- TOP 2022
- RNXT 2021
- Fundamental
- Price
- TOP $1.03
- RNXT $0.81
- Analyst Decision
- TOP
- RNXT Strong Buy
- Analyst Count
- TOP 0
- RNXT 2
- Target Price
- TOP N/A
- RNXT $7.50
- AVG Volume (30 Days)
- TOP 60.9K
- RNXT 395.2K
- Earning Date
- TOP 08-13-2025
- RNXT 11-13-2025
- Dividend Yield
- TOP N/A
- RNXT N/A
- EPS Growth
- TOP N/A
- RNXT N/A
- EPS
- TOP N/A
- RNXT N/A
- Revenue
- TOP $3,329,256.00
- RNXT $928,000.00
- Revenue This Year
- TOP N/A
- RNXT $2,895.35
- Revenue Next Year
- TOP N/A
- RNXT $313.04
- P/E Ratio
- TOP N/A
- RNXT N/A
- Revenue Growth
- TOP N/A
- RNXT N/A
- 52 Week Low
- TOP $1.00
- RNXT $0.70
- 52 Week High
- TOP $3.33
- RNXT $1.69
- Technical
- Relative Strength Index (RSI)
- TOP 34.31
- RNXT 37.36
- Support Level
- TOP $1.03
- RNXT $0.73
- Resistance Level
- TOP $1.07
- RNXT $0.87
- Average True Range (ATR)
- TOP 0.05
- RNXT 0.08
- MACD
- TOP -0.00
- RNXT -0.02
- Stochastic Oscillator
- TOP 20.37
- RNXT 22.92
About TOP TOP Financial Group Limited
TOP Financial Group Ltd is an online brokerage firm in Hong Kong specializing in trading local and overseas equities, futures, and options products. The Company generates brokerage commission income by enabling its customers to trade on multiple exchanges present globally. The company operates in only one segment which is the futures brokerage service.
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.